Research Article

Menthol Attenuates Hyperglycemia Induced Renal Oxidative Stress Damage via Amending Renal Biomarkers in Streptozotocin-Nicotinamide Induced Experimental Rats

Udaiyar Muruganathan1, Subramani Srinivasan1, 2,*, Veerasamy Vinothkumar1
1Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar – 608002, Tamilnadu, India
2Postgraduate and Research Department of Biochemistry, Government Arts College For Women, Krishnagiri- 635 001, Tamil Nadu, India
*Corresponding author:

S. Srinivasan, Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar- 608002; Tamilnadu, India; Tel: +91 04144 – 239343; Fax: +91 04144 – 239141; Email: sivaseenu77@gmail.com

Keywords:

Menthol, Enzymatic antioxidants, Streptozotocin-nicotinamide, Diabetes mellitus

Diabetes mellitus is characterised by hyperglycemia associated with the enhance of oxidative stress. Nephropathy is one of the most frequent complication in diabetes. With an objective to develop complementary and alternative medicine for the treatment of diabetic nephropathy, the present study explored the protective effect of menthol in streptozotocin-nicotinamide (STZ-NA) induced diabetic nephropathy. Diabetes was induced by single intraperitoneal (i.p.) injection of STZ (50 mg/kg/b.w) and NA (110 mg/kg/b.w). Diabetic rats were treated with menthol (50 mg/kg/b.w) and glibenclamide (600 μg/kg/b.w) daily for 45 days. Our results showed an improved levels of insulin, with significant decline in glucose, serum urea, uric acid and creatinine. The altered activities of superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST) and glutathione peroxidase (GPx) were restored to near normal. Histological evaluation revealed that abnormalities in renal tissues were significantly ameliorated by menthol intervention. In conclusion, our results demonstrated that menthol may rescue STZ-NA-induced diabetic nephropathy, through suppressing the oxidative stress and improved renal biomarkers.

Diabetes mellitus is a metabolic disorder of multiple etiologies, is characterized by hyperglycemia, in which diabetes without treatment commonly results in severe disability or diffuse glomerulosclerosis. Diabetic nephropathy is one of the major complications of diabetes mellitus and a leading cause of end-stage renal failure in the world, which is characterized by a series of renalstructure abnormalities, such as mesangial expansion,glomerulosclerosis and basement membrane thickening [1]. The etiology of diabetes is multiple; however, studies have related that oxidative stress plays a central role in the pathogenesis and complications of the disease.Preveous study reported that free radicals induced by hyperglycemia cause oxidative stress in the body that contributes to the development and progression of diabetes and other complications predominantly diabetic nephropathy [2]. Thereby, the amelioration of the imbalanced condition by enhancing the cellular antioxidant capacity may make some difference for a variety of pathology in diabetic nephropathy [3]. About 15-25 % of type 1 diabetes patients and 30-40% of patients with type 2 diabetes suffer from diabetic nephropathy. Approximately one-third to one-half of patients with diabetes develops diabetic nephropathy, which remains a major cause of morbidity and mortality [4]. Hence,the targets of managing diabetic nephropathy are to optimize the control of blood glucose, reduce the effects of oxidative stress and normalize disturbances in renal markers [5].The complications in the existing diabetic treatment have led to the employment of natural resources either as a food supplement or as a medicinal formulation.Plant-based nutraceuticals and supplements have been used in traditional medicine since antiquity.Indian traditional medicine formulates several herbs and the active principles are used in the treatment of diabetes since time immemorial [6]. Chemical and pharmacological research studies have identified numerous bioactive and nontoxic compounds in naturally occurring nutraceuticals and botanical drugs in efforts to find novel therapeutic agents for treatment of diabetic nephropathy [7]. Mono terpenoids receiving considerable attention across the world for the potential health benefits in relation to various diseases including diabetes and its complications. Menthol, a naturally occurring monocyclic terpene alcohol, is a key component of pepper mint oil, popular flavoring and cooling additive in several common household remedies (topical pain gels, throat lozenges, toothpaste), foods (gum, candies, teas). It has been widely used in cosmetics,pharmaceutical products and as flavoring in food [8].Recently, we have reported the antihyperglycemic nature of menthol by determining its ameliorating role on the activities of hepatic key glucose metabolic enzymes and attenuates pancreatic β-cell apoptosis in streptozotocinnicotinamide (STZ-NA)- induced experimental rats [9]. Given the above findings, it is plausible, we can speculate beneficial effect of menthol against hyperglycemiainduced renal oxidative stress. Therefore, the aim of this study was to evaluate the effect of menthol on biochemical and histological parameters in the kidney of STZ-NA-induced experimental rats.

Chemicals


Menthol, STZ and NA were purchased from Sigma Chemical Co (St. Louis, Mo. USA). All other chemicals and solvents were of analytical grade and purchased from Himedia Laboratories Pvt.Ltd, Mumbai, India.

Animals


Male albino Wistar rats (180–200 g) were bred in the Central Animal House, Department of Pharmacology, Rajah Muthiah Medical College and Hospital, Annamalai University, Tamil Nadu, India. The rats had free access to water and a commercial standard pelleted diet (Lipton India Ltd, Mumbai, India). The animals were housed in standard polypropylene cages and maintained under controlled room temperature (22 ± 2 °C) and humidity (55 ± 5%) with 12:12 h light and dark cycle. The rats used in the present study were maintained in accordance with the guidelines of the National Institute of Nutrition, Indian Council of Medical Research, Hyderabad, India. The study protocol was approved (Reg No.: 160/1999/CPCSEA, Proposal No.: 1122/2015) by the Committee for the Purpose of Control and Supervision on Experimental Animals at Annamalai University, Annamalainagar, Tamil Nadu,India.

Induction of diabetes in experimental animals


After 12 h of fasting, rats were given single injection of NA (dissolved in normal saline),intraperitoneally (i.p), at dose of 110 mg/kg. 15 min later, STZ at 50 mg/kg (in 0.1 M sodium citrate bu ffer,pH 4.5) was also injected i.p. STZ-NA injected rats were given 5% glucose for 24 h to prevent drug-induced hypoglycemia. After 72 h, glucose levels were measured with a glucose test meter (accucheck glucometer.Only rats with fasting glycemia over 250 mg/dL were considered diabetic. Treatment was commenced on the fourth day after STZ-NA injection which was considered as day one.

Experimental design


The rats were randomly segregated into five groups of six rats in each group. Menthol were dissolved in a vehicle solution of 1 mL of corn oil and glibenclamide was diluted in water and administered orally to experimental groups using intragastric tube daily morning for a period of 45 days. The experimental protocol (Table 1) was shown below:

Group I:

Normal control (vehicle treated)

Group II:

Normal rats received intra gastrically menthol (50 mg/kg b.w.) dissolved in 1 mL of corn oil

Group III:

Diabetic control (vehicle treated)

Group IV:

Diabetic rats received intra gastrically menthol (50 mg/kg b.w.) dissolved in 1 mL of corn oil

Group V:

Diabetic rats received intra gastrically glibenclamide (600 µg/kg b.w.) dissolved in 1 mL of water

Table 1. Experimental protocol.


On the last day of treatment, after an overnight fast,blood samples were collected from the orbital sinus and immediately centrifuged at 3500 ×g for 15 min to obtain the serum. All the rats were then killed by cervical dislocation. The kidneys were excised, blotted dry, and quickly weighed and used for pathological histology by hematoxylin and eosin (H&E) staining. The kidneys and serum were stored at −70 °C for further analyses.

Biochemical estimations


Plasma glucose levels were estimated using a commercial kit (Sigma Diagnostics Pvt. Ltd., Baroda,India) by the method of Trinder [10] and plasma insulin was determine using a rat ELISA kit (Lincoplex Ltd, St. Charles, MO) respectively. Plasma protein was determined by the method of Lowry et al. [11], using bovine serum albumin as the standard. Serum urea, uric acid, and creatinine were evaluated using commercially available diagnostic kits (Agappe Diagnostic Pvt. Ltd.,India). method of Kakkar et al. [12]. Catalase (CAT) Rotruck et al.[14] and glutathione peroxidase (GPx).

Assay of kidney enzymatic antioxidant status


Renal tissues were homogenized in 0.1 moi/L Tris HCI buffer, pH 7.4, and centrifuged at 12000 ×g for 30 min at 4 °C. The activity of antioxidant enzymes were evaluated with standard protocols with minor modification. Kidney supernatant was collected and used for assays of enzymatic antioxidants. The activity of superoxide dismutase (SOD) determined by the activity was measured by the method of Aebi [13]. The activity glutathione-S-transferase (GST) was deliberated using estimated according to method described previously [15].

Histopathological observation


H&E staining was done to analyse the protective role of menthol in the renal cells of all groups of rats as portrayed by Fischer et al. [16]. The kidney tissues were fixed in normal 10% neutral-buffered formalin for 48 h. Thereafter, the samples were dehydrated in a graded alcohol, embedded in paraffin wax and stained with H&E according to the standard protocol. After that,the pathological alterations in the kidney tissues were observed with a light microscope in a blinded manner.

Statistical analysis


The statistical significance of the data has been determined using one-way analysis of variance (ANOVA) and significant difference among treatment groups were evaluated by Duncan’s multiple range test(DMRT) [17]. The results were considered statistically significant at p<0.05. All statistical analyses were made using SPSS 16.0, SPSS Inc, and Cary, NC.

Efficacy of menthol on plasma glucose and insulin levels


To examine the efficacy of menthol on hyperglycemia, the levels of plasma glucose and insulin were detected. As depicted in Figure 1, the levels of plasma glucose and insulin in the diabetic rats were significantly higher than those of control animals.Meanwhile, treatments with menthol (50 mg/kg) and glibenclamide (600 μg/kg b.w.) effectively suppressed the levels of plasma glucose and enhanced the levels of insulin in STZ-NA-induced diabetic rats.

clyto access

clyto access
Figure 1. 1A Effect of menthol on plasma glucose.

Figure 1. 1B Effect of menthol on insulin levels. Each value is mean  S.D. for 6 rats in each group. In each graph line, means with different superscript letter (a-c) differ significantly at p<0.05 (DMRT). NC: Normal control, DC: Diabetic control, ML: Menthol, GE: Glibenclamide.

Effect of menthol on STZ-NA-induced oxidative stress in kidney


This paragraph talks about the effect of menthol on renal oxidative stress of the experimental groups was shown in Table 2. The activities of SOD, CAT, GST and GPx in the kidneys was significantly lowered in STZ-NA-induced diabetic rats compared to normal rats. Treatment with menthol and glibenclamide significantly up regulated the activities of enzymatic antioxidants in diabetic rats.

Effect of menthol on STZ-NA-induced oxidative stress in kidney


This paragraph talks about the effect of menthol on renal oxidative stress of the experimental groups was shown in Table 2. The activities of SOD, CAT, GST and GPx in the kidneys was significantly lowered in STZ-NA-induced diabetic rats compared to normal rats. Treatment with menthol and glibenclamide significantly up regulated the activities of enzymatic antioxidants in diabetic rats.

Parameters

NC

N + ML

DC

D + ML

D + GE

(50 mg/kg b.w)

(50 mg/kg b.w)

(600 µg/kg b.w)

SOD

 

 

 

 

 

kidney (Ua/mg protein)

    7.10 ± 0.54a

  7.50 ± 0.57a

    3.10 ± 0.24b

   5.23 ± 0.40c

     5.37± 0.41c

CAT

 

 

 

 

 

kidney (Ub/mg protein)

    44.64 ± 3.35a

  45.59 ± 3.45a

    23.23 ± 1.77b

   35.80 ± 2.74c

    37.23 ± 2.85c

GST

 

 

 

 

 

kidney (U/mg protein)

     6.39 ± 0.49a

   6.91 ± 0.53a

    2.91 ± 0.22b

   5.21 ± 0.40c

     5.24 ± 0.40c

GPx

 

 

 

 

 

kidney (Uc/mg protein)

     39.48 ± 3.01a

   40.12 ± 3.07a

   19.68 ± 1.50b

   30.13 ± 2.31c

    32.10 ± 2.46c

Values are given as mean  ± S.D from six rats in each group. Values not sharing a common superscript letter (a-c) differ significantly at p<0.05 (DMRT)

NC: Normal control, DC: Diabetic control, ML: Menthol, GE: Glibenclamide.  Ua - The amount of enzyme required to inhibit 50 % NBT reduction/ min for SOD.  Ub - Micromoles of H2O2 utilized/ per mg of protein for catalase. Uc - Micromoles of glutathione oxidized /mg of protein for GPx.

Table 2. Effect of menthol on the activities of renal enzymatic antioxidant in STZ-NA experimental rats.

Efficiency of menthol on STZ-NA-induced renal dysfunction in diabetic rats


Serum levels of kidney function markers such as urea, uric acid and creatinine serve as the diagnostic tools for the assessment of kidney function. Increased levels of these markers in serum are the indicators of renal dysfunction. Significant increase in the levels of urea, uric acid and creatinine were detected in diabetes group (Table 3). Administration of menthol significantly restored the serum levels of urea, uric acid and creatinine near to normal. However, treatment with menthol to normal rats did not cause significant alterations in the renal function markers.

Parameters

NC

N + ML

DC

D + ML

D + GE

(50 mg/kg b.w)

(50 mg/kg b.w)

(600 µg/kg b.w)

Total protein (mg/dL)

8.5   ± 0.65a

8.6   ± 0.66 a

3.91 ± 0.30b

7.24 ± 0.55c

7.58 ± 0.58c

Urea (mg/dL)

26.28 ± 2.0a

25.88 ± 1.98 a

56.83 ± 4.33b

31.82 ± 2.44c

30.57 ± 2.34c

Uric acid (mg/dL)

2.64 ± 0.20a

2.59 ± 0.20a

7.10 ± 0.54b

3.42 ± 0.26c

3.35 ± 0.26c

Creatinine (mg/dL)

0.48 ± 0.04a

0.46 ± 0.04a

1.87 ± 0.14b

0.74 ± 0.06c

0.72 ± 0.06c

Values are given as mean  ± S.D from six rats in each group. Values not sharing a common superscript letter (a-c) differ significantly at p<0.05 (DMRT) NC: Normal control, DC: Diabetic control, ML: Menthol, GE: Glibenclamide

Table 3. Effect of menthol on the levels of total protein, urea, uric acid, and creatinine in STZ-NA-induced experimental rats.

Efficacy of menthol on STZ-NA-induced kidney histology changes


To evaluate the protective role of mentho on physiological impairment, H&E staining was performed (Figure 2). Histological examination of renal tissue from control rats showed normal cell architecture (Figure 2A). Normal rats treated with menthol illustrated normal architecture and tubules with regular morphology (Figure 2B). By contrast,STZ-NA-induced damaged rats revealed severe tubular degeneration or necrosis, glomerular hypertrophy,narrowing of the lumen and interstitial inflammation (Figure 2C). Nevertheless, the severity of renal injury was attenuated by menthol and glibenclamide (Figure 2D and E).

clyto access

Figure 2.Represents the Photomicrographs of H&E staining of kidney tissues of control and experimental groups of rats. [A] Normal control rats. [B] Normal rats supplemented with menthol. [C] STZ-NA-induced experimental rats. [D] STZ-NA-induced diabetic rats intervention with menthol. [E] STZ-NA-induced diabetic rats treated with glibenclamide.

The current exploration reveals the renoprotective potential of menthol against hyperglycemia-mediated oxidative stress in STZ-NAinduced diabetic nephropathy. In our study, we found the pathophysiological alterations and deteriorated renal functions due to chronic hyperglycemia-mediated oxidative stress in the experimental rats. STZ-induced diabetic rats pretreated with NA have been reported as models for the evaluation of insulin secretagogues. STZNA experimental rats exhibited moderate hyperglycemia associated with the loss of postprandial early phase insulin secretion and the condition displays constant hyperglycemia, glucose intolerance and a significantly altered glucose-stimulated insulin secretion and contributes a number of features similar with human diabetes [18]. In the current hypothesis, we observed an increase in the level of plasma glucose and decrease in the level of insulin. Interestingly, treatment with menthol (50 mg/kg b.w.) significantly reduce plasma glucose levels in diabetic rats is due to its potential to secrete insulin from existing islet β-cells. The dose was determined based on our previous work [9] where the 50 mg/kg dose has been found to be therapeutically effective in fabricating antihyperglycemic efficacy in STZ-NA experimental rats. The observed increase in the level of plasma insulin indicates that menthol stimulates insulin secretion by the closure of K+-ATP channels, membrane depolarization and stimulation of Ca2+ influx, an initial key step in insulin secretion from the remnet β-cells. We substantiated aforementioned declaration that the effect by menthol might be stimulation of survival β-cells from islets Langerhans by closure of K+-ATP channels leading to more insulin release was proved by earlier study [19].

SOD catalyzes the dismutation of superoxide anion (O2•−) into hydrogen peroxide (H2O2), which is then degraded to H2O by CAT. A decrease in the activity of these antioxidants may lead to an excess of availability of O2•− and H2O2, which in turn generates hydroxyl radicals, resulting in SOD and CAT are reduced in renal tissues of STZ-NA rats found by current study.This may result in a number of injurious effects due to the accretion of reactive oxygen species (ROS) [20]. The probable mechanism for this diminution in SOD and CAT activities may be due to the inactivation caused by the excess of free radicals and/or by non-enzymatic glycation due to the persistent hyperglycemia. We originated that supplementation with menthol augmented the activities of SOD and CAT in STZ-NA rats. The results of our hypothesis demonstrated the increased activities these enzymes clearly illustrate that menthol has free radical scavenging property, which exerts a beneficial action against pathological alterations caused by ROS.

In addition, we found that the activity of GST was also declined in the kidney of diabetic rats. GST is an enzyme of crucial importance, mainly in the kidney,which catalyses the conjugation of reduced glutathione with toxic substances [21]. Inhibition of GST activity in STZ-NA rats can cause alterations in the major cellular defence strategies against xenobiotics. GPx protects the cells from lipid peroxidation and reduces the loss of membrane integrity by metabolizing H2O2, to H2O by using reduced glutathione as a hydrogen donor.The activity of GST and GPx were diminished due to the inactivation and glycation of the enzyme in STZNA-induced diabetic rats. Intervention with menthol restores the activities of these enzymatic antioxidants to near normal levels. Taken together, these findings suggest that menthol can strengthen the antioxidant enzymatic protection system, reduce free radicals and alleviate kidney damage caused by oxidative stress in STZ-NA experimental rats.

Meanwhile, next we determined the serum urea level, accumulation of urea nitrogen in experimental diabetes may due to the enhanced breakdown of both liver and plasma proteins. Alterations in nitrogen homeostasis may leads to increased hepatic elimination of urea nitrogen and increased peripheral release of nitrogenous substances. In the current study, diabetic rats exhibited renal damages that were evidenced by the elevation in serum urea levels, which are considered as significant markers of renal dysfunction [22]. Thus measurement of urea in serum is extremely useful for diagnostic purpose. Treatment with menthol decreased the levels of urea in STZ-NA-induced experimental rats and the findings suggest that menthol possesses the potential to attenuate renal injury caused by hyperglycemic state.

Uric acid, one of the major endogenous water-soluble antioxidants of the body, has been thought to be a metabolically inert end product of purine metabolism [23]. Our data showed that uric acid levels were increased in STZ-NA hyperglycemic rats. This may be due to metabolic disturbance in hyperglycemia reflected in high activities of xanthine oxidase [24]. Moreover, protein glycation in diabetes may lead to muscle wasting and increased release of purine, the main source of uric acid as well as in activity of xanthine oxidase [25]. Thus, the elevated levels of circulating uric acid may be an indicator that the body is trying to protect itself from the deleterious effect of free radicals by increasing the products of endogenous antioxidants,such as uric acid. In the present study, the improved levels of uric acid observed in STZ-NA experimental rats were restored to near normalcy by the administration of menthol indicating the free radical scavenging and hypoglycemic activity of menthol.

Hence, we subsequently attempted effect menthol on serum creatinine levels in STZ-NA-induced diabetic rats. Creatinine is excreted by kidneys into the urine and in normal conditions, its excretion is relatively constant,the amount of creatinine produced being proportional to the muscle mass of the individual. It is reported that hyperglycemia leads to an increased production of glomerular matrix proteins [26], the accumulation of which decreases the surface area for filtration leading to decreased glomerular filtration rate (GFR). Increased serum creatinine in diabetic rats is taken as an index of altered GFR in diabetic nephropathy [27]. Intervention with menthol reduced elevated levels of creatinine in diabetic rats, it possesses the potential to attenuate renal injury caused by hyperglycemic state and this can be associated directly with the antioxidant capacity of this monoterpene, which protects the kidneys against oxidative damage, as evidenced in this study.

The histopathology evaluation of kidney in normal control rats illustrated normal architectures of renal tissue. However, deterioration of kidney functions as observed in STZ-NA experimental rats was consistent with the histopathological changes in the kidneys as featured by altered renal architectures, glomerular atrophy and reduced surface area of the Bowman capsule. The STZ-NA induced histological alteration are in concord with previously reported study [28]. Our findings on menthol also strengthen the cutting edge research on monoterpene and notion that monoterpene have great potential in the management of diabetic nephropathy [29]. Menthol administration extensively improved the STZ-NA-induced histopathological changes and showed minimum tubular damage and less necrotic damage. The histopathological findings support other biochemical findings in experimental groups and indicate nephroprotective potential of menthol.

In conclusion, the present study exhibited that menthol may provide effective protection against oxidative stress damage in the kidney of STZ-NA experimental diabetes. Menthol may reduce free radical levels and enhanced enzymatic antioxidant defense in renal tissues and also improved renal damage markers in diabetic rats. These findings provide evidence that menthol may be useful for the treatment of renalcomplications associated with diabetes and can serve as an attractive therapeutical substitution for managing diabetic nephropathy. However, more molecular mechanistic studies are needed to delineate how exactly menthol protects in diabetic nephropathy before its further clinical investigation.

The authors of this article do not have any conflict of interest to disclose. No part of the manuscript has been submitted or is under consideration in any other publication.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

1. Khanra R, Bhattacharjee N, Dua TK, Nandy A, Saha A, et al. (2017) Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats. Biomed Pharmacother 94: 726-741.
2. Borgohain MP, Chowdhury L, Ahmed S, Bolshette N, Devasani K, et al. (2017) Renoprotective and antioxidative effects of methanolic Paederia foetida leaf extract on experimental diabetic nephropathy in rats. J Ethnopharmacol 198: 451-459.
3. Mestry SN, Dhodi JB, Kumbhar SB, Juvekar AR (2016) Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves extract. J Tradit Complement Med 7: 273-280.
4. Ostergaard J, Hansen TK, Thiel S, Flyvbjerg A (2005) Complement activation and diabetic vascular complications. Clin Chim Acta 361: 10-19.
5. Van Bommel EJ, Muskiet MH, Tonneijck L, Kramer MH, Nieuwdorp M, et al. (2017) SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome. Clin J Am Soc Nephrol 12: 700-710.
6. Porqueddu T (2017) Herbal medicines for diabetes control among Indian and Pakistani migrants with diabetes. Anthropol Med 24: 17-31.
7. Li W, Yuan G, Pan Y, Wang C, Chen H (2017) Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review. Front Pharmacol 23: 74.
8. Kamatou GP, Vermaak I, Viljoen AM, Lawrence BM (2013) Menthol: a simple monoterpene with remarkable biological properties. Phytochemistry 96: 15-25.
9. Muruganathan U, Srinivasan S, Vinothkumar V (2017) Antidiabetogenic efficiency of menthol, improves glucose homeostasis and attenuates pancreatic β-cell apoptosis in streptozotocin-nicotinamide induced experimental rats through ameliorating glucose metabolic enzymes. Biomed Pharmacother 92: 229-239.
10. Trinder P (1969) Determination of glucose in blood using glucose oxidase with analternative oxygen acceptor. Ann Clin Biochem 6: 24-27.
11. Lowry OH, Rosebrough NJ, Farr Al, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem.193: 265-275.
12. Kakkar S, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of SOD. Indian J Biochem Biophys 21: 130-132.
13. Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121-126.
14. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases the first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
15. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, et al. (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588-590.
16. Fischer AH, Jacobson KA, Rose J, Zeller R (2008) Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008.
17. Duncan BD (1957) Multiple ranges tests for correlated and heteroscedastic means. Biometrics 13: 359-364.
18. Ghasemi A, Khalifi S, Jedi S (2014) Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review). Acta Physiol Hung 101: 408-420.
19. Journigan VB, Zaveri NT (2013) TRPM8 ion channel ligands for new therapeutic applications and as probes to study menthol pharmacology. Life Sci 92: 425-437.
20. Jiang S, Wang Y, Ren D, Li J, Yuan G, et al. (2015) Antidiabetic mechanism of Coptis chinensis polysaccharide through its antioxidant property involving the JNK pathway. Pharm Biol 53: 1022-1029.
21. Samarghandian S, Borji A, Farkhondeh T (2017) Evaluation of Antidiabetic Activity of Carnosol (Phenolic Diterpene in Rosemary) in Streptozotocin-Induced Diabetic Rats. Cardiovasc Hematol Disord Drug Targets 17: 11-17.
22. Raish M, Ahmad A, Jan BL, Alkharfy KM, Ansari MA, et al. (2016) Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats. Int J Biol Macromol 91: 394-399.
23. Chu FY, Chang CC, Huang PH, Lin YN, Ku PW, et al. (2017) The Association of Uric Acid Calculi with Obesity, Prediabetes, Type 2 Diabetes Mellitus, and Hypertension. Biomed Res Int. 2017: 7523960.
24. Ashry OM, Hussein EM, Abd El-Azime AS (2017) Restorative role of persimmon leaf (Diospyros kaki) to gamma irradiation-induced oxidative stress and tissue injury in rats. Int J Radiat Biol 93: 324-329.
25. Mao ZM, Shen SM, Wan YG, Sun W, Chen HL, et al. (2015) Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. J Ethnopharmacol 173: 256-265.
26. Smith-Palmer T (2002) Separation methods applicable to urinary creatine and creatinine. J Chromatogr B Analyt Technol Biomed Life Sci 781: 93-106.
27. Zhang C, Li Q, Lai S, Yang L, Shi G, et al. (2017) Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats. J Ethnopharmacol 205: 207-216.
28. Chandran R, Parimelazhagan T, Shanmugam S, Thankarajan S (2016) Antidiabetic activity of Syzygium calophyl lifolium in Streptozotocin-Nicotinamide induced Type-2 diabetic rats. Biomed Pharmacother. 82: 547-554.
29. Motteleb DM, Aleem DI (2017) Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms. Clin Exp Pharmacol Physiol 44: 509-515.

Citation: Muruganathan U, Srinivasan S, Vinothkumar V (2017) Menthol Attenuates Hyperglycemia Induced Renal Oxidative Stress Damage via Amending Renal Biomarkers in Streptozotocin-Nicotinamide Induced Experimental Rats. J Diabetes Care Endocrinolo 1:003.

Published: 30 December 2017

Copyright:

© 2017 Muruganathan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.